Abstract:Gadolinium-based macromolecular magnetic resonance imaging (MRI) contrast agents (CAs) have attracted increasing interest in tumor diagnosis. However, their practical application is potentially limited because the long-term retention of gadolinium ion in vivo will induce toxicity. Here, a nanoglobular MRI contrast agent (CA) PAMAM-PG- g-s-s-DOTA(Gd) + FA was designed and synthesized on the basis of the facile host-guest interaction between β-cyclodextrin and adamantane, which initiated the self-assembly of poly(glycerol) (PG) separately conjugated with gadolinium chelates by disulfide bonds and folic acid (FA) molecule onto the surface of poly(amidoamine) (PAMAM) dendrimer, finally realizing the biodegradability and targeting specificity. The nanoglobular CA has a higher longitudinal relaxivity ( r1) than commercial gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA), showing a value of 8.39 mM-1 s-1 at 0.5 T, and presents favorable biocompatibility on the observations of cytotoxicity and tissue toxicity. Furthermore, MRI on cells and tumor-bearing mice both demonstrate the obvious targeting specificity, on the basis of which the effective contrast enhancement at tumor location was obtained. In addition, this CA exhibits the ability of cleavage to form free small-molecule gadolinium chelates and can realize minimal gadolinium retention in main organs and tissues after tumor detection. These results suggest that the biodegradable nanoglobular PAMAM-PG- g-s-s-DOTA(Gd) + FA can be a safe and efficient MRI CA for tumor diagnosis.

Gadolinium-based Nanoscale MRI Contrast Agents for Tumor Imaging

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Gadolinium-based contrast agents for tumor targeting imaging

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor <i>T</i><sub>1</sub> Magnetic Resonance Imaging

Magnetic Resonance Imaging Contrast Agent: Crgd-Ferric Oxide Nanometer Particle and Its Role in the Diagnosis of Tumor

Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor T 1 Magnetic Resonance Imaging

Aptamer-Targeted Magnetic Resonance Imaging Contrast Agents and Their Applications

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

In Vivo Tumor Visualization Through MRI Off‐On Switching of NaGdF4–CaCO3 Nanoconjugates

Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.

Progress in research of nanomedicine-based gadolinium contrast agents for magnetic resonance imaging

Small is Smarter: Nano MRI Contrast Agents – Advantages and Recent Achievements

A dual-targeted Gd-based contrast agent for magnetic resonance imaging in tumor diagnosis

Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.

Geometrical Confinement Directed Albumin-Based Nanoprobes As Enhanced T-1 Contrast Agents for Tumor Imaging

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Manganese Oxide Nanoparticles As MRI Contrast Agents in Tumor Multimodal Imaging and Therapy

Gadolinium Loaded Nanoparticles in Theranostic Magnetic Resonance Imaging.